| RS2149110899 |
MYT1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 39 |
| RS2149111820 |
ATP7A
|
Health Risk |
Likely pathogenic |
— |
| RS2149112121 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2149112273 |
ATP7A
|
Health Risk |
Likely pathogenic |
Menkes kinky-hair syndrome, Menkes kinky-hair syndrome |
| RS2149112301 |
ATP7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Menkes disease, mild |
| RS2149112377 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149112658 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149113303 |
PROM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 41, Retinitis pigmentosa 41 |
| RS2149113333 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2149113459 |
CFH
|
Health Risk |
Pathogenic/Likely pathogenic |
Factor H deficiency, Age related macular degeneration 4 |
| RS2149113551 |
ATP7A
|
Health Risk |
Likely pathogenic |
Menkes kinky-hair syndrome, Menkes kinky-hair syndrome |
| RS2149114379 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149117350 |
DEPDC5
|
Health Risk |
Pathogenic |
— |
| RS2149117486 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149117986 |
CFH
|
Health Risk |
Likely pathogenic |
Factor H deficiency, Factor H deficiency |
| RS2149118044 |
CFH
|
Health Risk |
Likely pathogenic |
— |
| RS2149118240 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Seizure, Seizure |
| RS2149118700 |
CFH
|
Health Risk |
Pathogenic/Likely pathogenic |
Factor H deficiency, Atypical hemolytic-uremic syndrome |
| RS2149118712 |
CFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemolytic uremic syndrome, atypical |
| RS2149118730 |
CFH
|
Health Risk |
Likely pathogenic |
— |
| RS2149119265 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149120039 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149120608 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2149120668 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149123423 |
NFKB1
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS2149125350 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia |
| RS2149125943 |
TRPC3
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 41, Spinocerebellar ataxia type 41 |
| RS2149126191 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2149127392 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149127726 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149127930 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2149127976 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS2149128829 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149128878 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149129071 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149129901 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149130255 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149132078 |
PGK1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, Glycogen storage disease due to phosphoglycerate kinase 1 deficiency |
| RS2149133294 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149134563 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149135116 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149135348 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149136105 |
ASXL2
|
Health Risk |
Likely pathogenic |
Shashi-Pena syndrome, Shashi-Pena syndrome |
| RS2149136134 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149136473 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149136521 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Melanoma |
| RS2149136994 |
PGK1
|
Health Risk |
Likely pathogenic |
— |
| RS2149137048 |
PGK1
|
Health Risk |
Likely pathogenic |
— |
| RS2149137069 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149137188 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149137273 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149137337 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149137694 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149138024 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2149138125 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149138245 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2149138656 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149139061 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Cardiomyopathy |
| RS2149139493 |
HAX1
|
Health Risk |
Pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS2149139668 |
HAX1
|
Health Risk |
Pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS2149139706 |
HAX1
|
Health Risk |
Pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS2149139793 |
HAX1
|
Health Risk |
Pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS2149139817 |
HAX1
|
Health Risk |
Pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS2149139969 |
HAX1
|
Health Risk |
Pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS2149140056 |
HAX1
|
Health Risk |
Pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS2149140065 |
HAX1
|
Health Risk |
Likely pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS2149140090 |
TRAK1
|
Health Risk |
Pathogenic |
Uterine corpus endometrial carcinoma, Uterine corpus endometrial carcinoma |
| RS2149140495 |
HAX1
|
Health Risk |
Pathogenic |
Kostmann syndrome, Hepatocellular carcinoma |
| RS2149140690 |
HAX1
|
Health Risk |
Likely pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS2149140738 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149142613 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149142768 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149143211 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149143657 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149146140 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149149399 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2149150540 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2149151527 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149151820 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2149152823 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149153407 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2149155486 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149156374 |
CAMTA1
|
Health Risk |
Pathogenic |
— |
| RS2149158164 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2149158986 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149160869 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149161607 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2149161840 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2149163148 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2149164388 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149164413 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149164661 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149164805 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2149165354 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149165704 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2149166157 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149168276 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2149168346 |
NFKB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency, common variable |
| RS2149169604 |
PROM1
|
Health Risk |
Pathogenic |
— |
| RS2149172097 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |